Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry
暂无分享,去创建一个
P. Sarzi-Puttini | R. Caporali | C. Klersy | G. Paolazzi | F. Atzeni | E. Favalli | E. Fusaro | S. Monti | A. Marchesoni | R. Pellerito | R. Gorla | P. A. Rocchetta